Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001669866-26-000005

CEO AND PRESIDENT sold 122,918 shares at an average $81.49 ($10,016,381)

  • CEO AND PRESIDENT acquired 122,918 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garcia Marino CEO AND PRESIDENT 2026-03-12 Option exercise 10b5-1 +122,918 $6.70 $823,551 122,918 D: show line 1 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-12 Sale 10b5-1 −43,505 $80.69 $3,510,418 79,413 D: show line 2 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-12 Sale 10b5-1 −65,517 $81.74 $5,355,360 13,896 D: show line 3 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-12 Sale 10b5-1 −12,796 $82.60 $1,056,950 1,100 D: show line 4 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-12 Sale 10b5-1 −200 $83.38 $16,676 900 D: show line 5 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-12 Sale 10b5-1 −900 $85.53 $76,977 0 D: show line 6 in the form
Open-market sales · 122,918 sh · avg $81.49 · $10,016,381

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Garcia Marino CEO AND PRESIDENT 2026-03-12 Option exercise · Stock Option (Right to Buy) 10b5-1 −122,918 59,741 D: show line 7 in the form
Loading xslF345X05/ownership.xml…